
Chemotherapy-free regimens for lymphoma and new drug combinations for myeloma are among the ASH 2026 studies patients should watch.
A roundup of the latest news and updates for patients with multiple myeloma from CURE®.
There have been several updates in the field of multiple myeloma over the last several weeks. Here, CURE® looks back at some of the latest news and updates in that space.
Get more news and updates on






